dr. Tijs Merckaert
No current affiliation with UGent
Show
Sort by
-
Towards improved Parsortix® efficiency for circulating tumor cell enrichment in pancreatic cancer
-
- Conference Paper
- C3
- open access
Assessing recovery rates of mesenchymal and epithelial pancreatic tumor cells using the Parsortix system
-
- PhD Thesis
- open access
Unravelling AKT2 signalling in cancer through nanobody technology
(2021) -
- Journal Article
- A1
- open access
An AKT2-specific nanobody that targets the hydrophobic motif induces cell cycle arrest, autophagy and loss of focal adhesions in MDA-MB-231 cells
-
- Journal Article
- A1
- open access
Development and characterization of protein kinase B/AKT isoform-specific nanobodies